US7632514B2ExpiredUtilityA1
Universal carrier for targeting molecules to Gb3 receptor expressing cells
Est. expiryFeb 1, 2021(expired)· nominal 20-yr term from priority
C07K 2319/00A61K 2039/627A61P 43/00A61K 48/00A61K 39/385A61P 37/04A61K 38/00C07K 14/25A61K 2039/6037A61P 35/00
83
PatentIndex Score
11
Cited by
62
References
11
Claims
Abstract
The present invention concerns an universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein: STxB is the Shiga Toxin B subunit or a functional equivalent thereof, Z is an amino-acid devoided of sulfydryl group, n being 0, 1 or a polypeptide, Cys is the amino-acid Cysteine, and the use thereof for MHC class I and MHC class II presentation of antigens.
Claims
exact text as granted — not AI-modified1. A universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:
STxB is the Shiga Toxin B subunit or a functional equivalent thereof,
Z is an amino-acid devoid of a sulfhydryl group, n being 0, 1 or a polypeptide,
Cys is the amino-acid Cysteine, wherein said molecule is an antigen to be targeted to antigen presenting cells.
2. The universal carrier according to claim 1 wherein n is 0.
3. The universal carrier according to claim 1 or 2 wherein the molecule is covalently linked to the —S residue of the universal carrier by a —S—S—, a —S—CO—, a —S—CH 2 — or a —S—NH— linkage.
4. The universal carrier according to claim 1 or 2 wherein the universal carrier is covalently linked to an oligopeptide or a polypeptide by a —S—S—, or a —S—CO—, or a —S—CH 2 — or a —S—NH— linkage, and the molecule to be targeted is operably linked to said oligopeptide or polypeptide.
5. The universal carrier according to claim 4 wherein the universal carrier is covalently linked to a poly-lysine oligopeptide and the molecule to be targeted is nucleic acid or an oligo-nucleotide operably linked to the said poly-lysine moiety.
6. The universal carrier according to claim 3 wherein the molecule is a cytotoxic drug or a pro-drug to be targeted to tumor cells expressing Gb3 receptors.
7. A universal carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:
STxB is the Shiga Toxin B subunit or a functional equivalent thereof,
Z is an amino acid devoid of a sulfhydryl group, n being 0, 1 or a polypeptide,
Cys is the amino acid Cysteine, wherein said molecule is selected from the group of proteins, glycoproteins, nucleic acids encoding proteins and a combination thereof.
8. A universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:
STxB is the Shiga Toxin B subunit,
Z is an amino acid devoid of a sulfhydryl group, n being 0, 1 or a polypeptide,
Cys is the amino acid Cysteine, wherein said molecule is selected from the group of proteins, glycoproteins, nucleic acids encoding proteins and a combination thereof.
9. A universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following sequence:
(SEQ ID No; 1)
COOH-
MKKTLLIAASLSFFSASALATPDCVTGKVEYTKYNDDDTFTVKVGDKELF
TNRWNLQSLLLSAQITGMTVTIKTNACHNGGGFSEVIFRC-NH 2 .
10. A universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:
STxB is the Shiga Toxin B subunit,
Z is an amino acid devoid of a sulfhydryl group, n being 0, 1 or a polypeptide,
Cys is the amino acid Cysteine, wherein said molecule is a cytotoxic drug or a pro-drug to be targeted to tumor cells expressing Gb3 receptors.
11. A universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein:
STxB is the Shiga Toxin B subunit or a functional equivalent thereof,
Z is an amino-acid devoid of a sulfhydryl group, n being 0, 1 or a polypeptide,
Cys is the amino-acid Cysteine, wherein the molecule is selected from the group consisting of proteins, peptides, oligopeptides, glycoproteins, glycopeptides, nucleic acids, polynucleotides, and a combination thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.